Trial of High-Dose Rifampin in Patients With TB

NCT01408914 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Higher-Dose Rifampin

Sponsor

Harvard University Faculty of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]